Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia

Clinical trial NCT05640102 · RECRUITING

Trial details

NCT number: NCT05640102
Sponsor: BeiGene
Status: RECRUITING
Study type: OBSERVATIONAL

Waldenstrom Macroglobulinemia

Start date: 2023-03-03
Primary completion: 2026-12-01
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.